|
Martin Olin Andersen is a Senior Partner and Senior Investment Director in SLS Venture, a Scandinavian-based venture capital company. The fund is one of the largest investment funds in Scandinavia in the life science sector with approximately 270 million euros under management. Prior to joining SLS Venture in 2000 Mr. Andersen worked with PriceWaterhouse, within auditing and management consulting with the focus on medium to large companies. In 1996, he joined Novo Nordisk A/S, Corporate Finance (Denmark). From 1998 to 2000, Mr. Andersen was Novo Nordisk's Finance Director for Europe, the Middle East & Africa, based in Paris (France), and was responsible for finances, legal and IT in the region. He then joined Medicon Valley Capital in April 2000 as Investment Manager and CFO Mr. Andersen has broad-based international experience and a network made up of strong financial and legal skills and expertise. Mr Andersen holds a BSC in Business and Administration from Vestsjaellands Business School, a MSC in Auditing and Business Administration from Copenhagen Business School and an Executive MBA from Scandinavian International Management Institute. | 